NCT07702552

Brief Summary

This prospective, comparative study aims to evaluate the postoperative analgesic efficacy of ultrasound-guided Adductor Canal Block (ACB) combined with iPACK block versus Femoral Triangle Block (FTB) combined with selective tibial nerve block and obturator nerve block in patients undergoing arthroscopic anterior cruciate ligament (ACL) reconstruction. The primary objective is to determine which regional anesthesia regimen provides superior pain relief at rest and during movement. The secondary objectives include assessing morphine consumption, motor blockade using the Bromage score, patient satisfaction, and potential adverse effects of these anesthesia techniques.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Jul 2026Mar 2027

Study Start

First participant enrolled

July 1, 2026

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 8, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

Adductor Canal BlockiPACK BlockFemoral Triangle BlockKnee Arthroscopy

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS) for Pain at Rest and Movement

    Evaluating pain scores using the Visual Analog Scale (VAS) at rest and during knee flexion at 0, 1, 3, 6, 9, 12, 18, and 24 hours postoperatively

    Within the first 24 hours postoperatively

Secondary Outcomes (3)

  • Total Rescue Morphine Consumption

    Within the first 24 hours postoperatively

  • Motor Blockade Assessment using Bromage Score

    Within the first 24 hours postoperatively

  • Patient Satisfaction Score

    24 hours postoperatively

Study Arms (2)

ACB and iPACK Block Group

EXPERIMENTAL

Ultrasound-guided Adductor Canal Block (10ml levobupivacaine 0.2%) and iPACK block (15ml levobupivacaine 0.2%) combined with standard multimodal analgesia (Paracetamol + Diclofenac).

Procedure: Ultrasound-guided Adductor Canal Block (ACB)Procedure: Ultrasound-guided iPACK block

FTB, Tibial and Obturator Blocks Group

ACTIVE COMPARATOR

Ultrasound-guided Femoral Triangle Block (10ml levobupivacaine 0.2%), selective Tibial Nerve Block (5ml levobupivacaine 0.2%), and Obturator Nerve Block (10ml levobupivacaine 0.2%) combined with standard multimodal analgesia

Procedure: Ultrasound-guided Femoral Triangle Block (FTB)Procedure: Ultrasound-guided Selective Tibial Nerve BlockProcedure: Ultrasound-guided Obturator Nerve Block

Interventions

Ultrasound-guided administration of 10 mL levobupivacaine 0.2% into the adductor canal space to provide postoperative analgesia

ACB and iPACK Block Group

Ultrasound-guided administration of 15 mL levobupivacaine 0.2% into the space between the popliteal artery and the posterior capsule of the knee to provide posterior knee analgesia.

ACB and iPACK Block Group

Ultrasound-guided administration of 10 mL levobupivacaine 0.2% at the distal apex of the femoral triangle to provide anterior and medial knee analgesia

FTB, Tibial and Obturator Blocks Group

Ultrasound-guided administration of 5 mL levobupivacaine 0.2% around the tibial nerve in the popliteal fossa

FTB, Tibial and Obturator Blocks Group

Ultrasound-guided administration of 10 mL levobupivacaine 0.2% targeting the anterior and posterior branches of the obturator nerve within the fascial planes between the adductor muscles.

FTB, Tibial and Obturator Blocks Group

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 16 years and older
  • Patients undergoing elective arthroscopic anterior cruciate ligament (ACL) reconstruction
  • ASA physical status I-II
  • Indicated for spinal anesthesia
  • Provided informed consent

You may not qualify if:

  • Infection at the injection site
  • Spinal cord or lower limb nerve injury
  • Contraindications to regional anesthesia (Levobupivacaine)
  • Known allergy to Paracetamol or Diclofenac
  • Coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Bai S, Hu A, Li W, Chen Y, Li X, Song X, Liu D, Ba Y, Chen Q, Liu X, Li Y, Zhang H, Xie Y, Wang X. Comparing the analgesic effects of femoral triangle block and adductor canal block following total knee arthroplasty: a systematic review and meta-analysis. BMC Anesthesiol. 2025 Apr 23;25(1):202. doi: 10.1186/s12871-025-03073-3.

  • Jaeger P, Nielsen ZJ, Henningsen MH, Hilsted KL, Mathiesen O, Dahl JB. Adductor canal block versus femoral nerve block and quadriceps strength: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Anesthesiology. 2013 Feb;118(2):409-15. doi: 10.1097/ALN.0b013e318279fa0b.

  • Ghodki PS, Shalu PS, Sardesai SP. Ultrasound-guided adductor canal block versus femoral nerve block for arthroscopic anterior cruciate ligament repair under general anesthesia. J Anaesthesiol Clin Pharmacol. 2018 Apr-Jun;34(2):242-246. doi: 10.4103/joacp.JOACP_172_17.

MeSH Terms

Conditions

Anterior Cruciate Ligament InjuriesPain, Postoperative

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Nhan T Phan, MD. MSc

    Da Nang Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nhan Trong Phan, MD. MSc

CONTACT

Trong Nhan Phan

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2026

First Posted

July 14, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

July 14, 2026

Record last verified: 2026-07